Company Overview
- Headquarters
- 3 World Trade Center, New York NY
- Website
- metsera.com
- Employees
- 70
- Industry
- Biotech/Healthcare
Who is Metsera
Metsera is a clinical-stage biopharmaceutical company headquartered in New York City. Founded in 2022, Metsera employs 70 individuals. Metsera focuses on developing innovative medicines for obesity and metabolic diseases. Their portfolio encompasses oral, injectable, incretin, non-incretin, and combination therapies aimed at addressing multiple therapeutic targets. These therapies are designed to provide best-in-class profiles for weight loss treatment. Metsera's therapies are intended to meet the evolving needs of patients seeking effective weight management solutions. The company has secured significant funding, raising $290 million from prominent healthcare investors. Interested parties can learn more about Metsera and their groundbreaking research by visiting their website at metsera.com.
Company Leadership
Companies Similar to Metsera
Analyze industry trends and opportunities by examining competitors and companies comparable to Metsera, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 803 | Deerfield, IL | 2010 | ||
| Buffalo, NY | ||||